Timing of dornase alfa inhalation for cystic fibrosis-Reference-Cited by-同舟云学术

Timing of dornase alfa inhalation for cystic fibrosis

Published:2018-11-12 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Dentice Ruth¹,Elkins Mark²

Affiliation:

1. Royal Prince Alfred Hospital; Department of Respiratory Medicine; Level 11, E Block Missenden Road Camperdown New South Wales Australia NSW 2050

2. University of Sydney; Sydney Medical School; Edward Ford Building A27 Sydney Australia NSW 2006

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007923.pub5/epdf/full

Reference119 articles.

1. Evaluation of two different timings of Pulmozyme nebulisation in relation to chest physiotherapy in children with Cystic Fibrosis;Anderson;Journal of Cystic Fibrosis,2009

2. Timing of dornase alpha inhalation does not affect the efficacy of the airway clearance regimen in adults with cystic fibrosis: a randomised crossover trial;Bishop;Journal of Physiotherapy,2011

3. Dornase alpha and physiotherapy - which should be first? A randomised, double-blind, placebo-controlled trial in CF adults;Middleton;Pediatric Pulmonology,2001

4. A crossover, randomized, controlled trial of dornase alfa before versus after physiotherapy in cystic fibrosis;Fitzgerald;Pediatrics,2005

5. Is dornase alfa (Pulmozyme) more effective before or after physiotherapy? A cross-over, randomised, placebo-controlled trial;Fitzgerald;Pediatric Pulmonology,2001

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review of respiratory physiotherapy methods in patients with cystic fibrosis;Annales Academiae Medicae Silesiensis;2023-01-26

2. Use of mucoactive agents in cystic fibrosis: A consensus survey of Italian specialists;Health Science Reports;2022-06-06

3. Comparison of biosimilar Tigerase and Pulmozyme in long-term symptomatic therapy of patients with cystic fibrosis and severe pulmonary impairment (subgroup analysis of a Phase III randomized open-label clinical trial (NCT04468100));PLOS ONE;2021-12-23

4. Timing of dornase alfa inhalation for cystic fibrosis;Cochrane Database of Systematic Reviews;2021-03-09

5. Timing of hypertonic saline inhalation for cystic fibrosis;Cochrane Database of Systematic Reviews;2020-02-28